Anna-Maria Georgoudaki

Company: Glycostem Therapeutics

Job title: Sr R&D manager

Seminars:

Transforming the Treatment Landscape of Autoimmune Diseases with Glycostem’s NK Cell Therapies 1:00 pm

uNiKTM: from umbilical cord blood hematopoietic stem cells to clinically safe and efficient off-the-shelf NK cells  viveNK® CAR-NK cells employ multimodal synergistic enhancement of antigen-specific targeting against SLE B cells How to assess B cells depletion in autoimmune diseases? Are they really gone?Read more

day: Day Two Track A, PM